Table 3:

Demographic and socioeconomic characteristics associated with receipt of cancer-directed therapy in patients with specialized cancer assessment

Characteristic*RR (95% CI)
Univariable analysis
n = 7984
Multivariable analysis
n = 7984
Age, yr
 ≤ 60Ref.Ref.
 61–701.09 (0.97–1.23)1.06 (0.95–1.18)
 71–800.96 (0.85–1.09)0.98 (0.87–1.10)
 ≥ 810.49 (0.41–0.59)0.48 (0.40–0.57)
Sex
 MaleRef.Ref.
 Female0.88 (0.80–0.96)0.94 (0.86–1.03)
High comorbidity burden
 ADG < 10Ref.Ref.
 ADG ≥ 100.85 (0.77–0.94)0.92 (0.84–1.02)
Income quintile
 5th (highest)Ref.Ref.
 4th1.01 (0.88–1.16)0.99 (0.87–1.13)
 3rd1.01 (0.88–1.16)1.00 (0.88–1.15)
 2nd0.99 (0.86–1.14)0.99 (0.86–1.13)
 1st (lowest)0.81 (0.69–0.94)0.80 (0.69–0.93)
Residence
 UrbanRef.Ref.
 Rural1.05 (0.92–1.20)0.96 (0.82–1.12)
Time period of diagnosis
 2005–2010Ref.Ref.
 2011–20161.27 (1.17–1.39)1.20 (1.09–1.31)
Distance to nearest chemotherapy centre, km
 ≤ 10Ref.Ref.
 11–301.10 (0.99–1.22)1.05 (0.94–1.17)
 ≥ 311.11 (0.94–1.31)1.11 (0.93–1.32)
Type of first consultation
 Hepato-pancreaticobiliary surgeryRef.Ref.
 Oncology1.61 (1.46–1.76)1.61 (1.46–1.76)
  • Note: ADG = Aggregated Diagnosis Group, CI = confidence interval, Ref. = reference, RR = risk ratio.

  • * All variables presented were included in the model.

  • Medical or radiation oncology.